Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review.
Sciancalepore F, Lombardi N, Valdiserra G, Bonaso M, Cappello E, Hyeraci G, Crescioli G, Celani MG, Cantisani TA, Brunori P, Vecchi S, Bacigalupo I, Locuratolo N, Lacorte E, Vanacore N, Kirchmayer U. Sciancalepore F, et al. Among authors: valdiserra g. Neuroepidemiology. 2024 Oct 9:1-14. doi: 10.1159/000539577. Online ahead of print. Neuroepidemiology. 2024. PMID: 39380477 Free article.
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study.
Lucarini E, Benvenuti L, Di Salvo C, D'Antongiovanni V, Pellegrini C, Valdiserra G, Ciampi C, Antonioli L, Lambiase C, Cancelli L, Grosso A, Di Cesare Mannelli L, Bellini M, Ghelardini C, Fornai M. Lucarini E, et al. Among authors: valdiserra g. Front Pharmacol. 2024 Sep 20;15:1466824. doi: 10.3389/fphar.2024.1466824. eCollection 2024. Front Pharmacol. 2024. PMID: 39372212 Free PMC article.
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis.
Di Salvo C, D'Antongiovanni V, Benvenuti L, Fornai M, Valdiserra G, Natale G, Ryskalin L, Lucarini E, Mannelli LDC, Ghelardini C, Colucci R, Haskó G, Pellegrini C, Antonioli L. Di Salvo C, et al. Among authors: valdiserra g. J Drug Target. 2024 Sep;32(8):953-963. doi: 10.1080/1061186X.2024.2367563. Epub 2024 Jul 2. J Drug Target. 2024. PMID: 38864378
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Convertino I, Cazzato M, Tillati S, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Bonaso M, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: valdiserra g. Front Pharmacol. 2023 Sep 25;14:1244486. doi: 10.3389/fphar.2023.1244486. eCollection 2023. Front Pharmacol. 2023. PMID: 37818193 Free PMC article.
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Convertino I, Lorenzoni V, Gini R, Turchetti G, Fini E, Giometto S, Bartolini C, Paoletti O, Ferraro S, Cappello E, Valdiserra G, Bonaso M, Blandizzi C, Tuccori M, Lucenteforte E. Convertino I, et al. Among authors: valdiserra g. Pharmaceuticals (Basel). 2023 Mar 21;16(3):465. doi: 10.3390/ph16030465. Pharmaceuticals (Basel). 2023. PMID: 36986565 Free PMC article.
Monoclonal antibody therapies against SARS-CoV-2.
Focosi D, McConnell S, Casadevall A, Cappello E, Valdiserra G, Tuccori M. Focosi D, et al. Among authors: valdiserra g. Lancet Infect Dis. 2022 Nov;22(11):e311-e326. doi: 10.1016/S1473-3099(22)00311-5. Epub 2022 Jul 5. Lancet Infect Dis. 2022. PMID: 35803289 Free PMC article. Review.
19 results